Karriereverlauf von Antoine Béret
Ehemalige bekannte Positionen von Antoine Béret
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Trophos SA
 Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Vorstandsvorsitzender | 21.12.1998 | 10.11.2009 |
| Gründer | 21.12.1998 | - | |
| Crédit National SA | Corporate Officer/Principal | - | - |
Immunotech
 Immunotech BiotechnologyHealth Technology Immunotech develops immunoassays and monoclonal antibodies. The company is headquartered in Marseille, France. | Gründer | - | - |
Axenis SAS
 Axenis SAS BiotechnologyHealth Technology Part of genOway SA, Axenis SAS develops gene technology and products. The company is based in Paris, France. Axenis was acquired by genOway SA on September 04, 2018 for $0.23 million. | Vorsitzender | - | - |
Genoscience Pharma
 Genoscience Pharma BiotechnologyHealth Technology Genoscience Pharma is a French clinical-stage biotechnology company that develops novel lysosomotropic therapeutics to establish a new standard of care against cancer, autoimmune, and infectious diseases. The private company is based in Marseille, France and was founded in 2001 by Philippe Halfon. Its lead candidate, GNS561, is a phase 2 ready drug candidate that tackles cancer cells through autophagy modulation. Genoscience Pharma is also entering a phase 2 trial with GNS561. | Vorstandsvorsitzender | - | - |
| TRANSGENE | Direktor/Vorstandsmitglied | 01.01.2016 | - |
| Independent Dir/Board Member | 01.01.2016 | - |
Statistik
International
| Frankreich | 7 |
Operativ
| Chief Executive Officer | 2 |
| Founder | 2 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 6 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TRANSGENE | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Health Technology |
Genoscience Pharma
Genoscience Pharma BiotechnologyHealth Technology Genoscience Pharma is a French clinical-stage biotechnology company that develops novel lysosomotropic therapeutics to establish a new standard of care against cancer, autoimmune, and infectious diseases. The private company is based in Marseille, France and was founded in 2001 by Philippe Halfon. Its lead candidate, GNS561, is a phase 2 ready drug candidate that tackles cancer cells through autophagy modulation. Genoscience Pharma is also entering a phase 2 trial with GNS561. | Health Technology |
Axenis SAS
Axenis SAS BiotechnologyHealth Technology Part of genOway SA, Axenis SAS develops gene technology and products. The company is based in Paris, France. Axenis was acquired by genOway SA on September 04, 2018 for $0.23 million. | Health Technology |
Immunotech
Immunotech BiotechnologyHealth Technology Immunotech develops immunoassays and monoclonal antibodies. The company is headquartered in Marseille, France. | Health Technology |
| Crédit National SA | Finance |
- Börse
- Insiders
- Antoine Béret
- Erfahrung
